The latest news from academia, regulators
research labs and other things of interest
Posted: April 15, 2008
NANOIDENT Partners With Life Science and Technology Leaders to Detect Airborne Pathogens for European Defence Agency
(Nanowerk News) NANOIDENT Technologies AG, a leader in the development and manufacture of printed semiconductor-based optoelectronic sensors, today announced the closing of a multi-party agreement with German company microfluidic ChipShop to develop a unique airborne pathogen detection system for the European Defence Agency.
The goal of the project is to develop an autonomous lab-on-a-chip based system, called the PathoID-Chip, for the detection of airborne chemical and biological agents. The system will be able to simultaneously test for multiple pathogens, in a shorter time and with greater sensitivity than is possible with conventional test methods. Tests will be completed in minutes and will be repeated every ten minutes; statistically, this is less time than it should take for a person to become infected. As a result, the presence of harmful substances can be detected in minutes and action can then be taken to reduce exposure.
To achieve these goals, the project combines several novel technologies to collect a sample from the air, inject it into liquid, process it and perform analysis. Other partners in the project include Clemens GmbH, Bundeswehr Institute of Microbiology, Friedrich-Loeffler-Institute, Joanneum Research Forschungsgesellschaft mbH, and Bertin Technologies. NANOIDENT’s technology is a core element of the system, and represents a major advance in point-of-use testing. Because optoelectronic sensors are printed onto each chip, the system does not require laboratory handling or bulky, power-hungry, expensive optical readout equipment, making it much more portable, rugged, and tolerant of dust than conventional test systems. The proximity of the sensor to the sample also results in much higher sensitivity than conventional systems.
“Our unique printed sensor technology makes it possible to develop a truly mobile detection system, offering faster detection and minimizing exposure to harmful chemical and biological agents,” said Dr. Max Sonnleitner, VP of NANOIDENT’s Life Sciences division. “We are proud to contribute a key enabling technology to this innovative project and to be a part of such an outstanding team.”
About NANOIDENT Technologies AG
NANOIDENT—named by Red Herring as one of the world’s 100 leading technology companies—is the market leader in the development and manufacture of printed semiconductor-based optoelectronic sensors. The company’s core technology merges the latest breakthroughs in materials science and nanotechnology with modern printing techniques to create a new class of semiconductor devices. The revolutionary SEMICONDUCTOR 2.0™ Platform is the basis of the world’s first commercial printed photonic sensors, enabling a whole new generation of applications in the industrial, biometric, and life science markets.
NANOIDENT’s high speed, environmentally friendly manufacturing process utilizes liquid nanomaterials and additive production techniques. These liquids are used to print electronic circuits on a wide variety of surfaces, producing products in mere hours for prototype as well as high volume applications. The company’s printed semiconductor devices can be bendable, disposable, light, ultrathin, and large area. They have application specific spectral and electronic properties, and can contain light sources and light detectors as well as electronic circuits. These unique characteristics enable cost-effective, custom designed devices for applications such as industrial, chemical, biological, and biometric sensors.
Privately held, the company is headquartered in Linz, Austria, with subsidiaries in San Francisco, California; Nuremberg, Germany; and Grenoble, France.